Profile | GDS5420 / 237881_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 451 | 65 |
GSM1296119 | B_lesional_pre-dose | 145 | 46 |
GSM1296076 | C_lesional_pre-dose | 82.64 | 39 |
GSM1296092 | D_lesional_pre-dose | 68.73 | 38 |
GSM1296103 | E_lesional_pre-dose | 249.33 | 56 |
GSM1296078 | F_lesional_pre-dose | 43.46 | 29 |
GSM1296107 | G_lesional_pre-dose | 169.25 | 49 |
GSM1296109 | H_lesional_pre-dose | 164.53 | 48 |
GSM1296080 | I_lesional_pre-dose | 248.06 | 57 |
GSM1296090 | J_lesional_pre-dose | 108.12 | 44 |
GSM1296074 | K_lesional_pre-dose | 94.34 | 43 |
GSM1296111 | L_lesional_pre-dose | 173.39 | 49 |
GSM1296099 | M_lesional_pre-dose | 196.97 | 52 |
GSM1296086 | O_lesional_pre-dose | 89.96 | 41 |
GSM1296117 | P_lesional_pre-dose | 190.24 | 50 |
GSM1296113 | Q_lesional_pre-dose | 297.18 | 58 |
GSM1296096 | R_lesional_pre-dose | 180.63 | 51 |
GSM1296105 | S_lesional_pre-dose | 249.18 | 55 |
GSM1296098 | T_lesional_pre-dose | 632.43 | 71 |
GSM1296101 | U_lesional_pre-dose | 405.93 | 64 |
GSM1296121 | V_lesional_pre-dose | 205.08 | 52 |
GSM1296088 | W_lesional_pre-dose | 180.17 | 51 |
GSM1296082 | X_lesional_pre-dose | 80.82 | 40 |
GSM1296115 | Y_lesional_pre-dose | 193.17 | 51 |
GSM1296084 | Z_lesional_pre-dose | 181.02 | 51 |
GSM1296072 | B_lesional_day8 | 226.51 | 54 |
GSM1296069 | L_lesional_day8 | 216.12 | 52 |
GSM1296071 | P_lesional_day8 | 254.41 | 55 |
GSM1296070 | Y_lesional_day8 | 232.49 | 53 |
GSM1296073 | V_lesional_day8 | 150.26 | 48 |
GSM1296034 | A_lesional_day15 | 548.62 | 68 |
GSM1296041 | G_lesional_day15 | 182.05 | 50 |
GSM1296035 | R_lesional_day15 | 215.79 | 54 |
GSM1296038 | U_lesional_day15 | 300 | 59 |
GSM1296047 | B_lesional_day15 | 201.65 | 51 |
GSM1296039 | E_lesional_day15 | 192.5 | 52 |
GSM1296042 | H_lesional_day15 | 181.55 | 49 |
GSM1296043 | L_lesional_day15 | 192.09 | 50 |
GSM1296037 | M_lesional_day15 | 246.67 | 55 |
GSM1296046 | P_lesional_day15 | 206.91 | 51 |
GSM1296044 | Q_lesional_day15 | 387.12 | 62 |
GSM1296045 | Y_lesional_day15 | 242.93 | 54 |
GSM1296025 | C_lesional_day15 | 233.32 | 55 |
GSM1296033 | D_lesional_day15 | 117.35 | 44 |
GSM1296027 | I_lesional_day15 | 38.54 | 30 |
GSM1296032 | J_lesional_day15 | 172.51 | 50 |
GSM1296024 | K_lesional_day15 | 179.95 | 51 |
GSM1296031 | W_lesional_day15 | 217.23 | 53 |
GSM1296028 | X_lesional_day15 | 136.94 | 47 |
GSM1296029 | Z_lesional_day15 | 155.22 | 48 |
GSM1296026 | F_lesional_day15 | 51.99 | 31 |
GSM1296030 | O_lesional_day15 | 92.59 | 43 |
GSM1296040 | S_lesional_day15 | 237.43 | 55 |
GSM1296036 | T_lesional_day15 | 524.2 | 68 |
GSM1296048 | V_lesional_day15 | 169.49 | 49 |
GSM1296059 | A_lesional_day43 | 193.7 | 52 |
GSM1296066 | G_lesional_day43 | 209.33 | 52 |
GSM1296060 | R_lesional_day43 | 183.25 | 51 |
GSM1296063 | U_lesional_day43 | 186.76 | 51 |
GSM1296064 | E_lesional_day43 | 259.54 | 57 |
GSM1296067 | H_lesional_day43 | 221.74 | 52 |
GSM1296062 | M_lesional_day43 | 393.36 | 63 |
GSM1296068 | Q_lesional_day43 | 279.24 | 56 |
GSM1296050 | C_lesional_day43 | 117.21 | 44 |
GSM1296057 | D_lesional_day43 | 273.66 | 57 |
GSM1296052 | I_lesional_day43 | 74.16 | 39 |
GSM1296054 | J_lesional_day43 | 264.04 | 56 |
GSM1296049 | K_lesional_day43 | 225.94 | 55 |
GSM1296055 | W_lesional_day43 | 173.75 | 49 |
GSM1296053 | X_lesional_day43 | 234.21 | 55 |
GSM1296058 | Z_lesional_day43 | 167.44 | 50 |
GSM1296051 | F_lesional_day43 | 77.3 | 38 |
GSM1296056 | O_lesional_day43 | 130.96 | 47 |
GSM1296065 | S_lesional_day43 | 201.96 | 52 |
GSM1296061 | T_lesional_day43 | 558.98 | 69 |
GSM1296095 | A_non-lesional_pre-dose | 284.64 | 58 |
GSM1296120 | B_non-lesional_pre-dose | 195.16 | 51 |
GSM1296077 | C_non-lesional_pre-dose | 109.14 | 44 |
GSM1296093 | D_non-lesional_pre-dose | 367.87 | 62 |
GSM1296104 | E_non-lesional_pre-dose | 208.26 | 53 |
GSM1296079 | F_non-lesional_pre-dose | 125.1 | 45 |
GSM1296108 | G_non-lesional_pre-dose | 232.75 | 54 |
GSM1296110 | H_non-lesional_pre-dose | 284.79 | 57 |
GSM1296081 | I_non-lesional_pre-dose | 192.72 | 53 |
GSM1296091 | J_non-lesional_pre-dose | 70.19 | 37 |
GSM1296075 | K_non-lesional_pre-dose | 85.37 | 40 |
GSM1296112 | L_non-lesional_pre-dose | 261.63 | 55 |
GSM1296100 | M_non-lesional_pre-dose | 365.03 | 62 |
GSM1296087 | O_non-lesional_pre-dose | 80.14 | 41 |
GSM1296118 | P_non-lesional_pre-dose | 282.5 | 57 |
GSM1296114 | Q_non-lesional_pre-dose | 422.37 | 64 |
GSM1296097 | R_non-lesional_pre-dose | 157.61 | 48 |
GSM1296106 | S_non-lesional_pre-dose | 256.1 | 55 |
GSM1296102 | U_non-lesional_pre-dose | 432.84 | 64 |
GSM1296122 | V_non-lesional_pre-dose | 186.55 | 50 |
GSM1296089 | W_non-lesional_pre-dose | 351.94 | 61 |
GSM1296083 | X_non-lesional_pre-dose | 248.8 | 56 |
GSM1296116 | Y_non-lesional_pre-dose | 230.31 | 53 |
GSM1296085 | Z_non-lesional_pre-dose | 192.71 | 52 |